Imaging and Genetic Biomarkers for Alzheimer's Disease (ImaGene)


This four-year research study was to investigate the correlation between genes, proteins and brain imaging in aging and the development of Alzheimer's disease. Normal control subjects and persons with mild cognitive impairment who are age 50 and older may qualify. A study partner was required for all participants to provide collateral information. Participants had yearly visits consisting of neuropsychological testing, blood draw and magnetic resonance imaging (MRI) scan. This research project period has ended. If you have any questions, please send an email to This email address is being protected from spambots. You need JavaScript enabled to view it..

Sponsors: The Jim Easton Consortium for Alzheimer's Disease Drug Discovery and Biomarkers and the Lincy Foundation
Principal Investigator: Liana Apostolova, MD, MSCR
Co-Investigator: John Ringman, MD, MS, Giovanni Coppola, MD, and Daniel Geschwind, MD, PhD.